C12N 9/127
Rna-directed rna polymerase , i.e. rna replicase
Official title: {RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase}
C12N9/127 (Rna-directed rna polymerase , i.e. rna replicase) appears on 126 US grants and 170 published applications in this corpus.
Search patents in C12N- Granted patents
- 126
- Published applications
- 170
- Assignees
- 135
- Inventors
- 451
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 2 | 0 |
| 2001 | 6 | 2 |
| 2002 | 3 | 6 |
| 2003 | 6 | 11 |
| 2004 | 2 | 11 |
| 2005 | 3 | 7 |
| 2006 | 5 | 6 |
| 2007 | 1 | 6 |
| 2008 | 6 | 3 |
| 2009 | 3 | 1 |
| 2010 | 2 | 6 |
| 2011 | 5 | 9 |
| 2012 | 2 | 4 |
| 2013 | 3 | 6 |
| 2014 | 2 | 3 |
| 2015 | 5 | 8 |
| 2016 | 2 | 7 |
| 2017 | 2 | 5 |
| 2018 | 10 | 5 |
| 2019 | 5 | 5 |
| 2020 | 5 | 9 |
| 2021 | 4 | 3 |
| 2022 | 4 | 6 |
| 2023 | 2 | 9 |
| 2024 | 3 | 14 |
| 2025 | 4 | 8 |
| 2026 | 5 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered cells secreting therapeutic enzymes18 Aug 2026US 12,709,739 B2Cartesian Therapeutics, Inc.
- Microorganism for producing pantoic acid, and construction method therefor and application thereof21 Jul 2026US 12,686,878 B2Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences
- Cell-based reporter assay for screening inhibitors of coronavirus RNA-dependent RNA polymerase activity7 Jul 2026US 12,674,148 B2Korea Institute of Oriental Medicine
- Replicase cycling reaction (RCR) and the related SamRNA designs thereof5 May 2026US 12,618,068 B2
- Replicase cycling reaction (RCR)31 Mar 2026US 12,590,329 B2
- Artificial secoviridae satellite rnas1 Oct 2026US 2026/0297596 A1Flagship Pioneering Innovations Vii, LLC
- Artificial tombusviridae satellite rnas1 Oct 2026US 2026/0297598 A1Flagship Pioneering Innovations Vii, LLC
- Artificial tymovirales satellite rnas1 Oct 2026US 2026/0297606 A1Flagship Pioneering Innovations Vii, LLC
- Rna replicons, compositions and methods of use thereof24 Sep 2026US 2026/0286321 A1Able Sciences, Inc.
- Self-amplifying non-coding rna for targeted gene knockdown13 Aug 2026US 2026/0234618 A1The Regents of the University of California
Most cited
By later US patents
- Genetic constructs for delaying or repressing the expression of a target gene369US 6,573,099 B2Benitec Australia Limited · 2003
- Recombinant negative strand RNA virus expression-systems218US 5,166,057 AMount Sinai School of Medicine of the City University of New York · 1992
- Recombinant negative strand RNA virus expression systems and vaccines171US 5,854,037 AMount Sinai School of Medicine of the City University of New York · 1998
- Recombinant negative strand RNA virus expression systems and vaccines118US 5,820,871 AMount Sinai School of Medicine of the City University of New York · 1998
- Recombinant negative strand RNA virus expression systems93US 5,840,520 AAviron · 1998